Efficacy and tolerability of the ketogenic diet in Dravet syndrome - comparison with various standard antiepileptic drug regimen

Epilepsy Research

Volumn 109, Issue 1, 2015, Pages 81-89

  Dressler, Anastasia ^a   Trimmel Schwahofer, Petra ^a   Reithofer, Eva ^a   Mühlebner, Angelika ^a   Gröppel, Gudrun ^a   Reiter Fink, Edith ^a   Benninger, Franz ^a   Grassl, Roland ^a   Feucht, Martha ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Dravet syndrome; Epilepsy; Ketogenic diet; Status epilepticus

Indexed keywords

ANTICONVULSIVE AGENT; BROMIDE; CLOBAZAM; ETIRACETAM; STIRIPENTOL; TOPIRAMATE; VALPROIC ACID; 1,3 DIOXOLANE DERIVATIVE; BENZODIAZEPINE DERIVATIVE; FRUCTOSE; PIRACETAM;

ADD ON THERAPY; ADOLESCENT; ADULT; ARTICLE; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG TOLERABILITY; EPILEPTIC STATE; FEMALE; GENE MUTATION; HUMAN; KETOGENIC DIET; MAJOR CLINICAL STUDY; MALE; MYOCLONUS SEIZURE; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; SEVERE MYOCLONIC EPILEPSY IN INFANCY; THERAPY EFFECT; TONIC CLONIC SEIZURE; VAGUS NERVE STIMULATION; ANALOGS AND DERIVATIVES; EPILEPSIES, MYOCLONIC; GENETICS; INFANT; SEIZURES; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ANTICONVULSANTS; BENZODIAZEPINES; BROMIDES; CHILD; CHILD, PRESCHOOL; DIOXOLANES; EPILEPSIES, MYOCLONIC; FEMALE; FRUCTOSE; HUMANS; INFANT; KETOGENIC DIET; MALE; PIRACETAM; RETROSPECTIVE STUDIES; SEIZURES; TREATMENT OUTCOME; VAGUS NERVE STIMULATION; VALPROIC ACID; YOUNG ADULT;

EID: 84922662090     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2014.10.014     Document Type: Article

References (35)

1. Akiyama M., Kobayashi K., Yoshinaga H., Ohtsuka Y. A long-term follow-up study of Dravet syndrome up to adulthood. Epilepsia 2010, 51:1043-1052.
2. Brunklaus A., Ellis R., Reavey E., Forbes G.H., Zuberi S.M. Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome. Brain 2012, 135:2329-2336.
3. Caraballo R.H. Nonpharmacologic treatments of Dravet syndrome: focus on the ketogenic diet. Epilepsia 2011, 52(Suppl. 2):79-82.
4. Caraballo R.H., Cersosimo R.O., Sakr D., Cresta A., Escobal N., Fejerman N. Ketogenic diet in patients with Dravet syndrome. Epilepsia 2005, 46:1539-1544.
5. Cersosimo R.O., Bartuluchi M., Fortini S., Soraru A., Pomata H., Caraballo R.H. Vagus nerve stimulation: effectiveness and tolerability in 64 paediatric patients with refractory epilepsies. Epileptic Disord. 2011, 13:382-388.
6. Chiron C. Current therapeutic procedures in Dravet syndrome. Dev. Med. Child Neurol. 2011, 53(Suppl. 2):16-18.
7. Chiron C., Marchand M.C., Tran A., Rey E., d'Athis P., Vincent J., Dulac O., Pons G. Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet 2000, 356:1638-1642.
8. Dressler A., Stocklin B., Reithofer E., Benninger F., Freilinger M., Hauser E., Reiter-Fink E., Seidl R., Trimmel-Schwahofer P., Feucht M. Long-term outcome and tolerability of the ketogenic diet in drug-resistant childhood epilepsy - the Austrian experience. Seizure 2010, 19:404-408.
9. Dutton S.B., Sawyer N.T., Kalume F., Jumbo-Lucioni P., Borges K., Catterall W.A., Escayg A. Protective effect of the ketogenic diet in Scn1a mutant mice. Epilepsia 2011, 52:2050-2056.
10. Fountain N.B. Status epilepticus: risk factors and complications. Epilepsia 2000, 41:S23-S30.
11. Genton P. When antiepileptic drugs aggravate epilepsy. Brain Dev. 2000, 22:75-80.
12. Genton P., Velizarova R., Dravet C. Dravet syndrome: the long-term outcome. Epilepsia 2011, 52:44-49.
13. Genton P., Velizarova R., Dravet C. Dravet syndrome: the long-term outcome. Epilepsia 2011, 52(Suppl. 2):44-49.
14. Kang H.C., Kim Y.J., Kim D.W., Kim H.D. Efficacy and safety of the ketogenic diet for intractable childhood epilepsy: Korean multicentric experience. Epilepsia 2005, 46:272-279.
15. Korff C., Laux L., Kelley K., Goldstein J., Koh S., Nordli D. Dravet syndrome (severe myoclonic epilepsy in infancy): a retrospective study of 16 patients. J. Child Neurol. 2007, 22:185-194.
16. Kossoff E.H. International consensus statement on clinical implementation of the ketogenic diet: agreement, flexibility, and controversy. Epilepsia 2008, 49(Suppl. 8):11-13.
17. Kossoff E.H., Bosarge J.L., Miranda M.J., Wiemer-Kruel A., Kang H.C., Kim H.D. Will seizure control improve by switching from the modified Atkins diet to the traditional ketogenic diet?. Epilepsia 2010, 51:2496-2499.
18. Kroll-Seger J., Portilla P., Dulac O., Chiron C. Topiramate in the treatment of highly refractory patients with Dravet syndrome. Neuropediatrics 2006, 37:325-329.
19. Laux L., Blackford R. The ketogenic diet in Dravet syndrome. J. Child Neurol. 2013, 28:1041-1044.
20. Lee P.R., Kossoff E.H. Dietary treatments for epilepsy: management guidelines for the general practitioner. Epilepsy Behav. 2011, 21:115-121.
21. Lotte J., Haberlandt E., Neubauer B., Staudt M., Kluger G.J. Bromide in patients with SCN1A-mutations manifesting as Dravet syndrome. Neuropediatrics 2012, 43:17-21.
22. Luan G., Zhao Y., Zhai F., Chen Y., Li T. Ketogenic diet reduces Smac/Diablo and cytochrome c release and attenuates neuronal death in a mouse model of limbic epilepsy. Brain Res. Bull. 2012, 89:79-85.
23. Maydell B.V., Wyllie E., Akhtar N., Kotagal P., Powaski K., Cook K., Weinstock A., Rothner A.D. Efficacy of the ketogenic diet in focal versus generalized seizures. Pediatr. Neurol. 2001, 25:208-212.
24. Nabbout R., Copioli C., Chipaux M., Chemaly N., Desguerre I., Dulac O., Chiron C. Ketogenic diet also benefits Dravet syndrome patients receiving stiripentol: a prospective pilot study. Epilepsia 2011, 52:e54-e57.
25. Nabbout R., Mazzuca M., Hubert P., Peudennier S., Allaire C., Flurin V., Aberastury M., Silva W., Dulac O. Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES). Epilepsia 2010, 51:2033-2037.
26. Neal E.G., Chaffe H., Schwartz R.H., Lawson M.S., Edwards N., Fitzsimmons G., Whitney A., Cross J.H. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 2008, 7:500-506.
27. Oguni H., Hayashi K., Awaya Y., Fukuyama Y., Osawa M. Severe myoclonic epilepsy in infants - a review based on the Tokyo Women's Medical University series of 84 cases. Brain Dev. 2001, 23:736-748.
28. Oguni H., Hayashi K., Oguni M., Mukahira A., Uehara T., Fukuyama Y., Umezu R., Izumi T., Hara M. Treatment of severe myoclonic epilepsy in infants with bromide and its borderline variant. Epilepsia 1994, 35:1140-1145.
29. Ragona F., Granata T., Dalla Bernardina B., Offredi F., Darra F., Battaglia D., Morbi M., Brazzo D., Cappelletti S., Chieffo D., De Giorgi I., Fontana E., Freri E., Marini C., Toraldo A., Specchio N., Veggiotti P., Vigevano F., Guerrini R., Guzzetta F., Dravet C. Cognitive development in Dravet syndrome: a retrospective, multicenter study of 26 patients. Epilepsia 2011, 52:386-392.
30. Sakauchi M., Oguni H., Kato I., Osawa M., Hirose S., Kaneko S., Takahashi Y., Takayama R., Fujiwara T. Retrospective multiinstitutional study of the prevalence of early death in Dravet syndrome. Epilepsia 2011, 52:1144-1149.
31. Scheffer I.E. Genetics of the epilepsies: channelopathies and beyond. Epilepsia 2011, 52:192-193.
32. Skluzacek J.V., Watts K.P., Parsy O., Wical B., Camfield P. Dravet syndrome and parent associations: the IDEA League experience with comorbid conditions, mortality, management, adaptation, and grief. Epilepsia 2011, 52(Suppl. 2):95-101.
33. Spatola M., Jeannet P.Y., Pollo C., Wider C., Labrum R., Rossetti A.O. Effect of vagus nerve stimulation in an adult patient with Dravet syndrome: contribution to sudden unexpected death in epilepsy risk reduction?. Eur. Neurol. 2013, 69:119-121.
34. Wirrell E.C., Laux L., Franz D.N., Sullivan J., Saneto R.P., Morse R.P., Devinsky O., Chugani H., Hernandez A., Hamiwka L., Mikati M.A., Valencia I., Le Guern M.E., Chancharme L., de Menezes M.S. Stiripentol in Dravet syndrome: results of a retrospective U.S. study. Epilepsia 2013, 54:1595-1604.
35. Zamponi N., Passamonti C., Cappanera S., Petrelli C. Clinical course of young patients with Dravet syndrome after vagal nerve stimulation. Eur. J. Paediatr. Neurol. 2011, 15:8-14.